Mithra logo.jpg
Mithra announces update to the agenda of its upcoming special general shareholders’ meeting
11 oct. 2023 01h00 HE | Mithra Pharmaceuticals
             Liege, Belgium, 11 October 2023 – 7:00 CEST – Mithra (Euronext Brussels: MITRA) (the "Company"), a company dedicated to Women’s Health, today announces that it has received a...
Mithra logo.jpg
Mithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congress
10 oct. 2023 12h00 HE | Mithra Pharmaceuticals
Mithra to hold joint symposium with partner Gedeon Richter on 11 OctoberFour leading experts will outline why estrogens are critical in contraception and postmenopausal symptomsData show promising...
Mithra logo.jpg
Mithra Provides an Update in the Context of Recent Market Developments
05 oct. 2023 01h00 HE | Mithra Pharmaceuticals
Mithra Provides an Update in the Context of Recent Market Developments Financial results show Mithra has solid financial foundation and multiple options to financeShareholder meetings called to...
Mithra logo.jpg
Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen at NAMS 2023
27 sept. 2023 01h00 HE | Mithra Pharmaceuticals
Independent global leaders in medical research on women’s health, Professor Amanda Black and Professor Wulf Utian, to deliver two presentations each on E4E4 is a key active pharmaceutical ingredient...
Mithra logo.jpg
Mithra Financial Results for First-Half 2023
26 sept. 2023 01h00 HE | Mithra Pharmaceuticals
Mithra Financial Results for First-Half 2023 Good progress on strategy to strengthen balance sheet and refocus on innovative R&DRevenues EUR 7.0 million, driven by Estelle® and Myring®...
Mithra logo.jpg
Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h 00 CET
22 sept. 2023 07h30 HE | Mithra Pharmaceuticals
Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h 00 CET Liège, Belgique, 22 septembre 2023 – 13 h 30 CET –...
Mithra logo.jpg
Information on the total number of voting rights (denominator)
21 sept. 2023 11h55 HE | Mithra Pharmaceuticals
Information on the total number of voting rights (denominator) Liege, Belgium, 21 September 2023 – 5:45 pm CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today...
Mithra logo.jpg
Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST
21 sept. 2023 11h55 HE | Mithra Pharmaceuticals
Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST Liege, Belgium, September 21, 2023 – 5:45 pm CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to...
Mithra logo.jpg
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
12 sept. 2023 11h45 HE | Mithra Pharmaceuticals
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 12 September 2023 – 5:45 pm CEST – Mithra...
Mithra logo.jpg
Publication of a Transparency Notification Received from Armistice Capital, LLC
12 sept. 2023 11h45 HE | Mithra Pharmaceuticals
Publication of a Transparency Notification Received from Armistice Capital, LLC Liege, Belgium, 12 September 2023 – 5:45pm CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s...